EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Receives Consensus Rating of “Buy” from Brokerages

Posted by Stacy Sanders on Jan 10th, 2026

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) has received an average recommendation of “Buy” from the six ratings firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company.

Several brokerages have commented on ESLOY. Royal Bank Of Canada reissued an “outperform” rating on shares of EssilorLuxottica in a research report on Tuesday, October 28th. Citigroup reissued a “buy” rating on shares of EssilorLuxottica in a research report on Thursday, December 11th. The Goldman Sachs Group restated a “buy” rating on shares of EssilorLuxottica in a report on Friday, December 5th. UBS Group raised shares of EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a research note on Thursday, November 27th. Finally, Zacks Research cut EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th.

Get Our Latest Report on EssilorLuxottica

EssilorLuxottica Trading Up 2.1%

ESLOY opened at $162.38 on Monday. The company has a debt-to-equity ratio of 0.18, a quick ratio of 0.67 and a current ratio of 0.97. EssilorLuxottica has a 52 week low of $118.60 and a 52 week high of $186.81. The business has a 50 day moving average of $171.14 and a 200-day moving average of $160.96.

EssilorLuxottica Company Profile

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.